alert icon COVID-19 INFO

Coming to a Cleveland Clinic location?
Visitation, mask requirements and COVID-19 information

Department Hematology and Medical Oncology
Primary Location Cleveland Clinic Main Campus
Type of Doctor Adults Only
Languages English, Hindi, Panjabi, Urdu
Surgeon No
Locations
Cleveland Clinic Main Campus
Primary Location

Cleveland Clinic Main Campus

Appointment:
866.320.4573
Desk:
216.445.8760
Fax:
216.444.9464
Specialties & Treatments

Treatment & Services

  • Cancer Center
View all 1 Treatment & Services +

Specialty in Diseases & Conditions

  • Acute Lymphocytic Leukemia (ALL)
  • Acute Myeloid Leukemia
  • Chronic Myelogenous Leukemia
  • Chronic Myelomonocytic Leukemia (CMML)
  • Clonal Cytopenia of Undetermined Significance (CCUS)
  • Clonal Hematopoiesis of Indeterminate Potential (CHIP)
  • Essential Thrombocythemia
  • Myelodysplastic Syndrome (MDS)
  • Myelofibrosis
  • Myeloproliferative Neoplasms
  • Polycythemia
View all 11 Specialties +
Insurance

Insurance

Is Cleveland Clinic Part of Your Insurance?

Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.

View All Plans
Biography

About Abhay Singh, MD, MPH

Dr. Abhay Singh focusses on clinical research in precursor conditions leading to hematologic malignancies with a specific focus on myeloid malignancies. His research interests involve studying clonal hematopoiesis of indeterminate potential (CHIP) and Clonal Cytopenias of Undetermined Significance (CCUS); entities implicated in the development of hematological malignancies and cardiovascular diseases, and, with opportunities for prevention in both fields.

Dr. Singh earned his bachelor of medicine and bachelor of surgery (MBBS) at Government Medical College, Amritsar, India. His interest in studying therapeutic and prognostic implications of cancer genomics in myeloid malignancies and pre-malignant states originated during his residency, from his lab and clinical research experience at Yale Cancer Center and Yale School of Public Health. During his residency, he was awarded the James Jekel Preventative Medicine Award (2018), award recognizing outstanding residents in the field of preventative medicine. He additionally earned awards by American College of Physicians recognizing his research efforts as Best Research Abstract in the state of Connecticut (2017) and Young Achievers Recognition (2018). Later, during his hematology and oncology fellowship at Roswell Park Comprehensive Cancer Center (RPCCC), he continued to explore the clonal diversity of myeloid malignancies, with an overarching goal of myeloid malignancy prevention. During his time as a fellow, his research garnered several accolades, namely Conquer Cancer Foundation - Syndax Pharmaceuticals Inc. Endowed Merit Award (2020) and American Society of Hematology Abstract Achievement Award (2020). In 2021, Dr. Singh received the Best Resident and Fellow Research Award at RPCCC, award that recognizes one resident or fellow from numerous disciplines for their outstanding research and contribution to science. To build up on these accomplishments, pursue his goals and with a hope to positively influence the outcomes of patients with myeloid malignancies, he has joined us at the Cleveland Clinic as a faculty member within the leukemia department.

Education & Professional Highlights

Education & Professional Highlights

Appointed
2021

Education & Fellowships

Fellowship - Roswell Park Cancer Institute
Hematology & Oncology
Buffalo, NY USA
2021

Residency - Griffin Hospital (Connecticut)
Internal Medicine and Preventive Medicine
Derby, CT USA
2018

Graduate School - Yale School of Public Health
New Haven, CT USA
2017

Medical Education - Government Medical College (India)
Amritsar, India
2011

Certifications

  • Internal Medicine
  • Internal Medicine - Medical Oncology
  • Internal Medicine - Hematology

Awards & Honors

  • Best Resident/Fellow research award (Clinical Science Category)-June 2021
  • American Society of Hematology Abstract Achievement Award-October 2020
  • Conquer Cancer Foundation-Syndax Parmaceuticals Inc. Endowed Merit Award - May 2020
  • James Jekel Preventative  Medicine  Award-May 2018
  • American College of physicians (ACP) Young Achievers Recognition-April 2018
  • ACP  Best  Original  Research  Award/Abstract in Connecticut  State-October 2017
  • Resident of the year award, Griffin Hospital, Derby Connecticut-May 2016
  • Physician  Training  Award in  Cancer  Prevention by American Cancer Society-July 2015
Research & Publications

Research & Publications

See publications for Abhay Singh, MD, MPH.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 1/11/2022, Dr. Singh has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Patient Satisfaction Reviews

38 Patient Satisfaction Reviews

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Cleveland Clinic.

Overall Star Ratings
4.9 out of 5
Explains 4.9
Listens 4.7
Courtesy, Respect & Concern 4.9
Patient Rating of Doctor 5

8 Patient Comments

Reviewed on Oct 24, 2022

Dr.Singh has been excellent in helping me with my leukemia.

Reviewed on Oct 7, 2022

Dr. Singh is very thorough and informative. He is concern with all heath problems and not just the CMML. I would highly recommend him to everyone.

Reviewed on Mar 17, 2022

Doctor was very kind professional and extremely informative

Reviewed on Jan 31, 2022

Dr. Singh in oncology was very knowledgeable and caring.

Reviewed on Jan 14, 2022

Dr. Singh and the staff were great.

Reviewed on Jan 13, 2022

Great first experience at Cleveland. Dr was amazing and answered all my questions. Really eased my mind.

Reviewed on Jan 7, 2022

The care provider was so kind and knowledgeable were so lucky to have him as my moms physician I want to continue Dr Singh as my mom's doctor

Reviewed on Nov 11, 2021

Dr. Singh is excellent.

Back to Top